JP2004138610A5 - - Google Patents

Download PDF

Info

Publication number
JP2004138610A5
JP2004138610A5 JP2003334210A JP2003334210A JP2004138610A5 JP 2004138610 A5 JP2004138610 A5 JP 2004138610A5 JP 2003334210 A JP2003334210 A JP 2003334210A JP 2003334210 A JP2003334210 A JP 2003334210A JP 2004138610 A5 JP2004138610 A5 JP 2004138610A5
Authority
JP
Japan
Prior art keywords
antibody
pro245
polypeptide
pro245 polypeptide
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003334210A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004138610A (ja
JP4040004B2 (ja
Filing date
Publication date
Priority claimed from PCT/US1998/019437 external-priority patent/WO1999014241A2/en
Application filed filed Critical
Publication of JP2004138610A publication Critical patent/JP2004138610A/ja
Publication of JP2004138610A5 publication Critical patent/JP2004138610A5/ja
Application granted granted Critical
Publication of JP4040004B2 publication Critical patent/JP4040004B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003334210A 1997-11-21 2003-09-25 Ａ−３３関連抗原およびそれらの薬理学的使用 Expired - Fee Related JP4040004B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6636497P 1997-11-21 1997-11-21
US7893698P 1998-03-20 1998-03-20
PCT/US1998/019437 WO1999014241A2 (en) 1997-09-17 1998-09-17 Compositions and methods for the treatment of immune related diseases

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2000522240A Division JP3497133B2 (ja) 1997-11-21 1998-11-20 Ａ−３３関連抗原およびそれらの薬理学的使用

Publications (3)

Publication Number Publication Date
JP2004138610A JP2004138610A (ja) 2004-05-13
JP2004138610A5 true JP2004138610A5 (enExample) 2005-06-09
JP4040004B2 JP4040004B2 (ja) 2008-01-30

Family

ID=38175777

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2000522240A Expired - Fee Related JP3497133B2 (ja) 1997-11-21 1998-11-20 Ａ−３３関連抗原およびそれらの薬理学的使用
JP2003334209A Expired - Fee Related JP3950097B2 (ja) 1997-11-21 2003-09-25 Ａ−３３関連抗原およびそれらの薬理学的使用
JP2003334210A Expired - Fee Related JP4040004B2 (ja) 1997-11-21 2003-09-25 Ａ−３３関連抗原およびそれらの薬理学的使用
JP2007056461A Expired - Lifetime JP4382827B2 (ja) 1997-11-21 2007-03-06 Ａ−３３関連抗原およびそれらの薬理学的使用

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2000522240A Expired - Fee Related JP3497133B2 (ja) 1997-11-21 1998-11-20 Ａ−３３関連抗原およびそれらの薬理学的使用
JP2003334209A Expired - Fee Related JP3950097B2 (ja) 1997-11-21 2003-09-25 Ａ−３３関連抗原およびそれらの薬理学的使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2007056461A Expired - Lifetime JP4382827B2 (ja) 1997-11-21 2007-03-06 Ａ−３３関連抗原およびそれらの薬理学的使用

Country Status (11)

Country Link
EP (3) EP2014677A1 (enExample)
JP (4) JP3497133B2 (enExample)
AT (3) ATE393786T1 (enExample)
AU (1) AU735081B2 (enExample)
CA (1) CA2309358A1 (enExample)
CY (1) CY1108212T1 (enExample)
DE (3) DE69837897T2 (enExample)
DK (2) DK1481989T3 (enExample)
ES (3) ES2288649T3 (enExample)
PT (2) PT1481989E (enExample)
WO (1) WO1999027098A2 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6951924B2 (en) 1997-03-14 2005-10-04 Human Genome Sciences, Inc. Antibodies against secreted protein HTEBYII
US6878806B2 (en) 1997-03-14 2005-04-12 Human Genome Sciences, Inc. Human secreted protein HTEEB42
US7968689B2 (en) * 1997-03-07 2011-06-28 Human Genome Sciences, Inc. Antibodies to HSDEK49 polypeptides
US8007798B2 (en) 1997-11-21 2011-08-30 Genentech, Inc. Treatment of complement-associated disorders
US8088386B2 (en) 1998-03-20 2012-01-03 Genentech, Inc. Treatment of complement-associated disorders
US7419663B2 (en) 1998-03-20 2008-09-02 Genentech, Inc. Treatment of complement-associated disorders
US7192589B2 (en) 1998-09-16 2007-03-20 Genentech, Inc. Treatment of inflammatory disorders with STIgMA immunoadhesins
AU6498499A (en) * 1998-09-17 2000-04-03 Genentech Inc. Compositions and methods for the treatment of immune related diseases
AU3902600A (en) * 1999-09-15 2001-04-17 Genentech Inc. Compositions and methods for the treatment of immune related diseases
JP4897690B2 (ja) * 2004-10-12 2012-03-14 ジェネンテック， インコーポレイテッド 補体関連障害の予防および処置のためのＣＲＩｇポリペプチド
KR20150055628A (ko) 2005-11-04 2015-05-21 제넨테크, 인크. 안질환 치료를 위한 보체 경로 억제제의 용도
DK2097455T3 (en) 2006-11-02 2014-12-15 Genentech Inc HUMANIZED ANTI-FACTOR D ANTIBODIES
AR066660A1 (es) 2007-05-23 2009-09-02 Genentech Inc Prevencion y tratamiento de condiciones del ojo asociadas con su complemento
CR20170001A (es) 2008-04-28 2017-08-10 Genentech Inc Anticuerpos anti factor d humanizados
TWI508973B (zh) 2008-05-06 2015-11-21 建南德克公司 親和力成熟之ＣＲＩｇ變體
US10093978B2 (en) 2013-08-12 2018-10-09 Genentech, Inc. Compositions for detecting complement factor H (CFH) and complement factor I (CFI) polymorphisms
MA39934A (fr) 2014-05-01 2017-03-08 Hoffmann La Roche Variants d'anticorps anti-facteur d et leurs utilisations
WO2017075173A2 (en) 2015-10-30 2017-05-04 Genentech, Inc. Anti-factor d antibodies and conjugates
WO2017075252A1 (en) 2015-10-30 2017-05-04 Genentech, Inc. Anti-factor d antibody variant conjugates and uses thereof

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873A (en) 1846-12-05 Im p rovem ent in loo ms fo r w e avi ng w re-gauz e
US191A (en) 1837-05-08 Machine for facing and dressing stone
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
FR2413974A1 (fr) 1978-01-06 1979-08-03 David Bernard Sechoir pour feuilles imprimees par serigraphie
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
JPS6023084B2 (ja) 1979-07-11 1985-06-05 味の素株式会社 代用血液
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
NZ201705A (en) 1981-08-31 1986-03-14 Genentech Inc Recombinant dna method for production of hepatitis b surface antigen in yeast
US4640835A (en) 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
AU2353384A (en) 1983-01-19 1984-07-26 Genentech Inc. Amplification in eukaryotic host cells
US4713339A (en) 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
US4579827A (en) 1983-03-11 1986-04-01 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4675187A (en) 1983-05-16 1987-06-23 Bristol-Myers Company BBM-1675, a new antibiotic complex
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US4496689A (en) 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
US4736866A (en) 1984-06-22 1988-04-12 President And Fellows Of Harvard College Transgenic non-human mammals
EP0199141A3 (en) 1985-04-19 1988-07-20 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies to human gastrointestinal cancer
DE3675588D1 (de) 1985-06-19 1990-12-20 Ajinomoto Kk Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist.
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
WO1987005330A1 (en) 1986-03-07 1987-09-11 Michel Louis Eugene Bergh Method for enhancing glycoprotein stability
US4791192A (en) 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
US4973478A (en) * 1987-07-20 1990-11-27 Allelix Biopharmaceuticals, Inc. Treating inflammation with hepatocyte stimulating factor interferon β2
US5010182A (en) 1987-07-28 1991-04-23 Chiron Corporation DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides
IL87737A (en) 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells
GB8724885D0 (en) 1987-10-23 1987-11-25 Binns M M Fowlpox virus promotors
AU633248B2 (en) 1987-12-21 1993-01-28 University Of Toledo, The Agrobacterium mediated transformation of germinating plant seeds
AU4005289A (en) 1988-08-25 1990-03-01 Smithkline Beecham Corporation Recombinant saccharomyces
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
AU4752790A (en) * 1988-11-16 1990-06-12 Brigham And Women's Hospital Inhib, a factor which inhibits cytokine-activated leukocytes
FR2646437B1 (fr) 1989-04-28 1991-08-30 Transgene Sa Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
DK0479909T3 (da) 1989-06-29 1997-04-07 Medarex Inc Bispecifikke reagenser til AIDS-behandling
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
ES2246502T3 (es) 1990-08-29 2006-02-16 Genpharm International, Inc. Animales no humanos transgenicos capaces de producir anticuerpos heterologos.
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
CA2095633C (en) 1990-12-03 2003-02-04 Lisa J. Garrard Enrichment method for variant proteins with altered binding properties
US5206161A (en) 1991-02-01 1993-04-27 Genentech, Inc. Human plasma carboxypeptidase B
JPH06507398A (ja) 1991-05-14 1994-08-25 リプリジェン　コーポレーション Ｈｉｖ感染治療のための異種複合抗体
MX9204374A (es) 1991-07-25 1993-03-01 Idec Pharma Corp Anticuerpo recombinante y metodo para su produccion.
US5756096A (en) 1991-07-25 1998-05-26 Idec Pharmaceuticals Corporation Recombinant antibodies for human therapy
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
DK0617706T3 (da) 1991-11-25 2001-11-12 Enzon Inc Multivalente antigenbindende proteiner
EP0669836B1 (en) 1992-11-13 1996-07-03 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma
ES2141128T3 (es) 1993-03-24 2000-03-16 Berlex Biosciences Combinacion de agentes anti-hormonales y moleculas de fijacion.
US5650295A (en) * 1995-06-02 1997-07-22 Human Genone Sciences, Inc. Macrophage migration inhibitory factor-3
US5665701A (en) 1994-11-17 1997-09-09 The Research Foundation Of State University Of New York Platelet membrane glycoprotein F11 and polypeptide fragments thereof
JPH11511004A (ja) * 1995-05-04 1999-09-28 シティ・オブ・ホープ ヒト白血球１２−リポキシゲナーゼおよび疾病状態の病因でのその役割
US6458939B1 (en) 1996-03-15 2002-10-01 Millennium Pharmaceuticals, Inc. Compositions and methods for the diagnosis, prevention, and treatment of neoplastic cell growth and proliferation
WO1999046281A2 (en) * 1998-03-10 1999-09-16 Genentech, Inc. Novel polypeptides and nucleic acids encoding the same
SE9604470D0 (sv) * 1996-12-04 1996-12-04 Tamas Bartfai Konsulting Ab Transmembrane component of tight junction
CA2283678A1 (en) * 1997-03-14 1998-09-17 Human Genome Sciences, Inc. 28 human secreted proteins
WO1998042739A2 (en) * 1997-03-21 1998-10-01 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US6358707B1 (en) * 1997-07-10 2002-03-19 Smithkline Beecham Corporation Human F11 antigen: a novel cell surface receptor involved in platelet aggregation
EP1241180B1 (en) * 1998-03-20 2008-07-30 Genentech, Inc. Human A33 antigen-like protein and nucleic acids encoding it

Similar Documents

Publication Publication Date Title
JP2004138610A5 (enExample)
AU2017378492B2 (en) Variant libraries of the immunological synapse and synthesis thereof
KR101621643B1 (ko) 다중 pcr 반응에서 증폭 바이어스를 측정 및 교정하기 위한 조성물 및 방법
KR100512819B1 (ko) 종양 치료용 조성물 및 방법
US20070048301A1 (en) Compositions and methods for the treatment of immune related diseases
EP1220905A2 (en) Composition and methods for the treatment of immune related diseases
JP2014528714A5 (enExample)
JP2005027667A5 (enExample)
KR20040073586A (ko) 종양 치료용 조성물 및 방법
US20090148898A1 (en) Human Ron-Related Gene Variant Associated With Cancers
US20050158740A1 (en) Variants of human glycoprotein hormone alpha chain: compositions and uses thereof
JP2004513614A5 (enExample)
JP2008507253A5 (enExample)
JP2004535161A5 (enExample)
CA2400638A1 (en) 7 human ovarian and ovarian cancer associated proteins
JP2004515215A5 (enExample)
JP2003507029A5 (enExample)
WO1991012272A1 (en) Protein factor
JP2002522021A5 (enExample)
WO1999055716A1 (en) A gene associated with nijmegen breakage syndrome, its gene product and methods for their use
CN1646703A (zh) 诊断和治疗与人转酮酶样－1基因过表达有关的增殖异常的组合物和方法
EP1895004A1 (en) Human hippocalcin gene variant associated with cancers
CA2504679A1 (en) Compositions and methods for the treatment of tumor
US20060040285A1 (en) Human kinase interacting protein 2 (KIP2)-related gene variant associated with cancers
WO2000008468A1 (en) Method of determining cell or tissue type by transmembrane receptor identifiers